Company intelligence
Alexion Pharmaceuticals, Inc.
Transforming Lives, Every Day.
About Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease. A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities. As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy
Verified activity
Signals from Alexion Pharmaceuticals, Inc.
9 published signals
Research & Knowledge
Alexion Pharmaceuticals, Inc. is investigating technologies designed to enable more targeted delivery to tissues of interest by pairing sequence-specific design with tissue-directed delivery.
Reported by Seng H. Cheng
People
Alexion Pharmaceuticals, Inc. is hiring for a career opportunity in Athlone.
Reported by Thomas Finneran
People
Alexion Pharmaceuticals, Inc. is hiring a regional account manager for the Rare Neurology team covering Boston South and Rhode Island.
Reported by Todd Quinn
People
Alexion Pharmaceuticals, Inc. is hiring a US Patient Marketing Director on the rare nephrology marketing team.
Reported by Jawad "Jay" Sabbah
People
Alexion Pharmaceuticals, Inc. appointed Holly Johnson as Associate Director, Sales & Operations – aHUS | HSCT-TMA.
Reported by Holly Johnson
People
Alexion Pharmaceuticals, Inc. appointed John Harris as US Medical Director, Digital Innovation and Capabilities.
Reported by John Harris
People
Alexion Pharmaceuticals, Inc. promoted Jason Lebowitz to Principal Medical Science Liaison on the Rare Neurology team.
Reported by Jason Lebowitz, PharmD, MSHS
Research & Knowledge
Alexion Pharmaceuticals, Inc. Head of Research and Product Development Seng Cheng reflects on patient insights, scientific creativity, and serial innovation in shaping rare disease R&D.
Reported by Alexion Pharmaceuticals, Inc.
People
Alexion Pharmaceuticals, Inc. is hiring senior managers for medical data strategy and activity in Boston.
Reported by Peter Covitz